Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,281,532
+$6,045 QoQ
Shares Held
5,046
-3.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2,752
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bell Bank holds $61,862,123 across 10 Drug Manufacturers - General names. JNJ ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
53,948 | $13,575,473 | |
| 2 | AMGN |
Amgen Inc
|
33,672 | $12,193,303 | |
| 3 | PFE |
Pfizer Inc
|
484,403 | $11,664,423 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
78,616 | $9,932,345 | |
| 5 | GSK |
GSK plc
|
181,234 | $9,500,285 | |
| 6 | LLY |
ELI LILLY & Co
|
2,255 | $2,704,714 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
5,046 | $1,281,532 | |
| 8 | MRK |
Merck & Co., Inc.
|
3,672 | $471,852 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,281,532 | 5,046 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,275,487 | 5,218 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,067,241 | 5,157 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $997,374 | 5,379 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $831,876 | 5,446 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $701,171 | 4,228 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $635,460 | 4,394 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $693,454 | 4,279 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $625,418 | 4,279 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,395,552 | 8,822 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,146,709 | 7,316 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $643,091 | 4,129 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $657,610 | 3,973 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $576,135 | 3,717 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $656,608 | 3,717 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $687,745 | 4,210 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $861,278 | 4,852 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $645,826 | 3,644 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $621,155 | 3,631 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $586,406 | 3,631 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $622,881 | 3,781 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $621,407 | 3,781 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $595,053 | 3,781 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $358,056 | 2,405 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $501,345 | 3,565 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $467,478 | 3,565 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||